Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Four-site, Randomized, Parallel Design, Double-blind, Placebo-controlled, 10-week Trial of Donepezil 10 mg Daily for Verbal Memory Problems Among Adults With TBI in the Subacute or Chronic Recovery Period

NCT02255799 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02255799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02255799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Four-site, Randomized, Parallel Design, Double-blind, Placebo-controlled, 10-week Trial of Donepezil 10 mg Daily for Verbal Memory Problems Among Adults With TBI in the Subacute or Chronic Recovery Period
Lead sponsor
Baylor College of Medicine
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2013
Completion date
December 4, 2024
Enrollment
75 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

memory deficits, traumatic brain injury